|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
2.07/2.87
|
企業價值
9.86B
|
資產負債 |
每股賬面淨值
11.92
|
現金流量 |
現金流量率
0.03
|
損益表 |
收益
2.07B
|
每股收益
17.91
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/01/21 18:54 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSICALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific. |